Efficacy and safety of incretin-based drugs in patients with type 1 diabetes mellitus: A systematic review and meta-analysis
Diabetes Research and Clinical Practice(2017)
Abstract
•Incretin-based drugs can improve glycemic control in patients with T1DM.•Incretin-based drugs can reduce insulin dose and weight in patients with T1DM.•Incretin-based drugs may not increase the risk of serious adverse event in patients with T1DM.
MoreTranslated text
Key words
Type 1 diabetes,DPP-4,GLP-1,Incretin
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined